Maunakea Technologies

See Cells. Change Lives.

Paris, France · Founded 2000 · $8.7M raised

Headquarters
Paris
Employees
51–200
Founded
2000
Business Model
B2B
Total Funding
$8.7M
Last Round
$8.7M Venture RoundDec 2019
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mauna Kea Technologies is a global medical device company that manufactures and commercializes Cellvizio®, the world's leading real-time in vivo cellular imaging platform using Confocal Laser Endomicroscopy (CLE). The platform enables physicians to accelerate diagnosis, guide treatment decisions, and improve surgical precision across gastroenterology, interventional pulmonology, and urology — with over 110,000 patient procedures performed and more than 1,300 published clinical papers. The company partners with industry leaders including Johnson & Johnson, Telix Pharmaceuticals, and Tasly Pharmaceutical.

Summary

Maunakea Technologies is a Biotech company based in Paris, France, founded in 2000. It has raised $8.7M in total across 1 round, most recently a $8.7M Venture Round in Dec 2019.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundStrategic Equity InvestmentDec 2019
$8.7M

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Maunakea Technologies on Indexed.vc
<a href="https://indexed.vc/companies/maunakea-technologies"><img src="https://indexed.vc/api/badge/company/maunakea-technologies" alt="Maunakea Technologies on Indexed.vc" width="260" height="76" /></a>